This inventor holds 13 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 1 EPO patent. Top assignees: Yamanouchi Pharmaceutical Company Ltd., Imperial Cancer Research Technology, Ltd., Ludwig Institute for Cancer Research Limited. Active years: 1993-2011.
Location History:
- Ibaraki, JP (1993 - 2001)
- Tsukuba, JP (2002 - 2011)
Company Filing History:
5 out of 329 
4 out of 27 
4 out of 530 
Years Active: 1993-2011
Title: The Innovative Contributions of Koyo Matsuda
Introduction
Koyo Matsuda is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit cancer cell growth. With a total of 13 patents to his name, Matsuda's work has the potential to impact cancer treatment significantly.
Latest Patents
Among his latest patents, Matsuda has developed fused heteroaryl derivatives. These inventions provide a pharmaceutical composition that serves as a phosphatidylinositol 3 kinase (PI3K) inhibitor and an antitumor agent. The novel bicyclic or tricyclic fused heteroaryl derivatives or their salts exhibit excellent PI3K inhibiting activity and cancer cell growth inhibiting activity.
Career Highlights
Throughout his career, Koyo Matsuda has worked with notable companies, including Yamanouchi Pharmaceutical Company Ltd. His innovative research and development efforts have led to advancements in pharmaceutical compositions that are crucial for cancer treatment.
Collaborations
Matsuda has collaborated with esteemed colleagues such as Masahiko Hayakawa and Hiroyuki Kaizawa. Their combined expertise has contributed to the success of his innovative projects.
Conclusion
Koyo Matsuda's contributions to the field of pharmaceuticals through his patents and collaborations highlight his dedication to advancing cancer treatment. His work continues to inspire future innovations in the industry.